Institution
ICM Partners
About: ICM Partners is a based out in . It is known for research contribution in the topics: Population & Breast cancer. The organization has 1311 authors who have published 1521 publications receiving 33745 citations. The organization is also known as: International Creative Management Partners.
Topics: Population, Breast cancer, Cancer, Cognition, Radiation therapy
Papers published on a yearly basis
Papers
More filters
••
5 citations
••
TL;DR: This revue a pour objectif d’analyser la relation entre l’Activite physique (AP) et le CDS, cette derniere etant une maladie associee au surpoids et a l”obesite au CDS.
5 citations
••
TL;DR: The originally published version of this Article contained an error in the subheading “Microglial GR does not affect DN loss triggered by TLR4 and TLR7,” which has now been corrected in both the PDF and HTML versions.
Abstract: The originally published version of this Article contained an error in the subheading “Microglial GR does not affect DN loss triggered by TLR4 and TLR7,” which was incorrectly given as “Microglial GR does affect DN loss triggered by TLR2 and TLR4”. This has now been corrected in both the PDF and HTML versions of the Article.
5 citations
••
TL;DR: A review of intensity-modulated radiation therapy planning issues, clinical toxicities and indications for breast cancer is proposed.
Abstract: Irradiation techniques for breast cancer (arctherapy, tomotherapy) are evolving and intensity-modulated radiation therapy is being increasingly considered for the management of these tumours. Here, we propose a review of intensity-modulated radiation therapy planning issues, clinical toxicities and indications for breast cancer.
5 citations
••
TL;DR: This review details the different radiobiological approaches that have been developed to better predict the tumor response but also the radiation-induced late effects.
Abstract: The impact of curative radiotherapy depends mainly on the total dose delivered homogenously in the target volume. Tumor sensitivity to radiotherapy may be particularly inconstant depending on location, histology, somatic genetic parameters and the capacity of the immune system to infiltrate the tumor. In addition, the dose delivered to the surrounding healthy tissues may reduce the therapeutic ratio of many radiation treatments. In a same population treated in one center with the same technique, it appears that individual radiosensitivity clearly exists, namely in terms of late side effects that are in principle non-reversible. This review details the different radiobiological approaches that have been developed to better predict the tumor response but also the radiation-induced late effects.
5 citations
Authors
Showing all 1311 results
Name | H-index | Papers | Citations |
---|---|---|---|
Alexis Brice | 135 | 870 | 83466 |
Bruno Dubois | 124 | 646 | 78784 |
Harald Hampel | 109 | 601 | 65160 |
Alexandra Durr | 104 | 594 | 47018 |
Laurent D. Cohen | 94 | 417 | 42709 |
Jürgen Eckert | 92 | 1368 | 42119 |
Stéphane Lehéricy | 89 | 332 | 27214 |
Antoine Danchin | 80 | 483 | 30219 |
Marie Vidailhet | 79 | 391 | 21836 |
Josep M. Gasol | 77 | 313 | 22638 |
Mélanie Boly | 76 | 232 | 21552 |
Etienne C. Hirsch | 75 | 218 | 22591 |
Måns Ehrenberg | 74 | 234 | 17637 |
Elizabeth M. C. Fisher | 74 | 298 | 21150 |
Isabelle Arnulf | 73 | 331 | 18456 |